Indofarma Tbk (INAF) — Cash Flow Quality Index
Indofarma Tbk (INAF) has a Cash Flow Quality Index of 25.56x as of September 2021. Operating cash flow of Rp47.20 Billion exceeds net income of Rp1.85 Billion, indicating high earnings quality where cash backs reported profits. Explore Indofarma Tbk (INAF) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Indofarma Tbk Cash Flow Quality Index (2000–2020)
Historical Cash Flow Quality Index for Indofarma Tbk across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Indofarma Tbk tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Indofarma Tbk (2000–2020)
Year-by-year earnings quality comparison for Indofarma Tbk. For live market cap and the full company financial profile, see INAF market cap.
| Year | Quality Index | Operating CF (IDR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 1687.69x | Rp46.55 Billion | Rp27.58 Million | ▲ +64522.4% |
| 2019 | 2.61x | Rp20.79 Billion | Rp7.96 Billion | ▼ -87.2% |
| 2015 | 20.45x | Rp134.28 Billion | Rp6.57 Billion | ▼ -84.0% |
| 2014 | 127.55x | Rp148.73 Billion | Rp1.17 Billion | ▲ +13312.9% |
| 2012 | -0.97x | Rp-40.91 Billion | Rp42.38 Billion | ▼ -221.2% |
| 2011 | 0.80x | Rp29.40 Billion | Rp36.92 Billion | ▼ -57.9% |
| 2010 | 1.89x | Rp23.71 Billion | Rp12.55 Billion | ▼ -90.1% |
| 2009 | 19.08x | Rp40.56 Billion | Rp2.13 Billion | ▲ +151.3% |
| 2008 | -37.22x | Rp-187.31 Billion | Rp5.03 Billion | ▼ -594.3% |
| 2007 | 7.53x | Rp83.42 Billion | Rp11.08 Billion | ▲ +56.9% |
| 2006 | 4.80x | Rp73.15 Billion | Rp15.24 Billion | ▲ +183.9% |
| 2005 | -5.72x | Rp-54.87 Billion | Rp9.59 Billion | ▼ -126.0% |
| 2004 | 22.00x | Rp159.25 Billion | Rp7.24 Billion | ▲ +8871.4% |
| 2000 | 0.25x | Rp27.05 Billion | Rp110.29 Billion | — |